Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0O1O stock hub

LON/0O1O has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0O1Ois not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

757M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0O1O

In the news

Latest news · LON/0O1O

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15

P25 12.9P50 16.9P75 23.5

Trailing P/E15.1

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC27.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0O1O market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

EUR

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	2,497
Employees Change	-4%
Employees Change Percent	-0.16
Enterprise value	EUR 615.6M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	FR0004186856
Last refreshed	2026-05-10
Market cap	EUR 757M
Price	EUR 73.9
Price currency	EUR
Rev Per Employee	183,662.97x
Sector	Healthcare
Sic	2834
Symbol	lon/0O1O
Website	https://www.vetoquinol.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.6%
EV Earnings	12.32x
EV/EBIT	9.1x
EV/EBITDA	6.29x
EV/Sales	1.36x
Forward P/E	15.04x
P/E ratio	15.14x
P/S ratio	1.65x
PE Ratio10 Y	22.07x
PE Ratio3 Y	16.09x
PE Ratio5 Y	18.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.89%
EBITDA Margin	21.57%
Gross margin	56.31%
Gross Profit	EUR 258.2M
Gross Profit Growth	-3.97%
Gross Profit Growth Q	-7.27%
Gross Profit Growth3 Y	0.98%
Gross Profit Growth5 Y	0.28%
Net Income	EUR 50M
Net Income Growth	-2.36%
Net Income Growth Q	-7.62%
Net Income Growth Years	0%
Net Income Growth3 Y	6.72%
Net Income Growth5 Y	-0.52%
Pretax Margin	15.26%
Profit Margin	10.9%
Profit Per Employee	EUR 20,019
Profitable Years	14
ROIC	27.71
Roic5y	17.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.15%
Cagr1y	2.32%
Cagr3y	-6.68%
Cagr5y	-5.8%
Div CAGR10	10.23%
Div CAGR3	3.02%
Div CAGR5	17.19%
EPS Growth Years	0
FCF Growth	1.15%
FCF Growth Q	37.91%
FCF Growth3 Y	-0.06%
FCF Growth5 Y	-4.09%
OCF Growth	-15.99%
OCF Growth Q	2.04%
OCF Growth10 Y	-2.43%
OCF Growth3 Y	-5.66%
OCF Growth5 Y	-7.41%
Revenue Growth	-2.5x
Revenue Growth Q	-2.44x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.74x
Revenue Growth5 Y	0.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	9.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	3.61%
Dividend Growth Years	5%
Dividend per share	EUR 0.75
Dividend Years	19
Dividend Yield	1.01%
Ex Div Date	2025-06-04
Last Dividend	EUR 0.75
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	99.42%
1Y total return	2.31%
200-day SMA	78.05
3Y total return	-18.72%
50-day SMA	80.75
50-day SMA vs 200-day SMA	50over200
5Y total return	-25.83%
All Time High	161.4
All Time High Change	-54.21%
All Time High Date	2021-11-05
All Time Low	34.35
All Time Low Change	115.14%
All Time Low Date	2015-01-22
ATR	1.76
Beta	0.9
Ch YTD	-12.02
High	74.7
High52	91.2
High52 Date	2026-02-16
High52ch	-18.97%
Low	73.9
Low52	69.2
Low52 Date	2025-06-17
Low52ch	6.79%
Ma50ch	-8.49%
Price vs 200-day SMA	-5.32%
RSI	37.42
RSI Monthly	42.62
RSI Weekly	41.99
Sharpe ratio	0.12x
Sortino ratio	0.42
Total Return	1.01%
Tr YTD	-12.02
Tr1m	-6.69%
Tr1w	-1.07%
Tr3m	-14.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 68.3M
Operating Income Growth	-2.16
Operating Income Growth Q	-2.67
Operating Income Growth3 Y	5.39
Operating Income Growth5 Y	-1.1
Operating margin	14.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,827,225%
Shares Insiders	4.02%
Shares Institutions	8.41%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	45.7x
Ch10y	83.42
Ch1m	-6.69
Ch1w	-1.07
Ch1y	1.09
Ch3m	-14.17
Ch3y	-21.07
Ch5y	-28.79
Ch6m	2.64
Change	-1.99%
Change From Open	-1.07
Close	75.4
Days Gap	-0.93
Depreciation Amortization	30,362,612.2
Earnings Date	2026-09-11
EBIT	EUR 68.3M
EBITDA	EUR 98.9M
F Score	3
Financing CF	-21,896,560
Fiscal Year End	December
Founded	1,933
Income Tax	EUR 20M
Investing CF	-17,970,882
Is Primary Listing	0
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Lynch Fair Value	EUR 24.4
Lynch Upside	-66.99
Ma150	79.05
Ma150ch	-6.51%
Ma20	78.4
Ma20ch	-5.73%
Net CF	16,138,899
Next Earnings Date	2026-09-11
Open	74.7
P OCF Ratio	12.04
Payment Date	2025-06-06
Position In Range	0
Price Date	2026-05-08
Price EBITDA	EUR 7.65
Relative Volume	7.34x
Revenue	458,606,434x
Tax By Revenue	4.36x
Tax Rate	28.55%
Tr6m	2.64%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0O1O dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$0.75 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+17.2%

5 consecutive years of growth

Total shareholder yield

+1.0%

Next ex-dividend date: 2025-06-04

Performance

LON/0O1O stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0O1O?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.4%

Share of float held by funds and institutions

Insider ownership

+4.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0O1O momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.4

Neutral momentum band

Price vs 200-day MA

-5.3%

50/200-day relationship not available

Beta (5Y)

0.90

Moves roughly with the market

Sharpe ratio

0.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0O1O

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0O1O stock rating?

lon/0O1O is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0O1O analysis?

The full report lives at /stocks/lon/0O1O/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0O1O?

The latest report frames lon/0O1O around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0O1O page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.